Product Images Dimethyl Fumarate

This is a description for Dimethyl Fumarate Delayed-Release Capsules USP, 120 mg. The capsules are dispensed in an original package. The text seems to contain information related to the product's composition and packaging, including dosage and the presence of a delayed-release mechanism.*

Each capsule of MAcLOD contains 120 mg of dimethyl fumarate, USP. It is a Delayed-Release Capsule to be taken orally. Instructions suggest storing between 15°C to 30°C (59°F to 86°F). This pharmaceutical product is manufactured by Macleods Pharma USA, Inc., and Macleods Pharmaceuticals Ltd. It is important to swallow the capsule whole and protect it from light. The dosage information is available in the insert.*

This text provides information about a medication named Dimethyl Fumarate, containing 240 mg, to be taken twice a day. The capsules are delayed-release and should be swallowed whole. The medication should be stored at controlled room temperature and protected from light. The product is manufactured by Macleods Pharma USA, Inc., and the contact information is provided.*

This is a table showing the percentage of subjects with confirmed progression of disability over time on study weeks. The data compares the placebo group to the Dimethyl Fumarate 240 mg BID group. Confirmed progression of disability is defined as at least a 10-point increase on the EDSS from a baseline EDSS greater than or equal to 10 confirmed for 12 weeks, or at least a 15-point increase on the EDSS from a baseline EDSS of 0 confirmed for 12 weeks.*

This is a description of Dimethyl Fumarate Delayed-Release Capsules USP. It includes information about packaging, storage temperature, and dosage form.*